0.83
price up icon0.30%   0.0025
after-market Handel nachbörslich: .81 -0.02 -2.41%
loading

Finanzdaten der Adaptimmune Therapeutics Plc Adr-Aktie (ADAP)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
2,358%
5.678
0.231 7.319 5.13 47.60
Operating Expenses
9.69%
54.94
50.09 53.95 50.04 45.95
Benefits Costs and Expenses
9.94%
53.66
48.80 52.23 25.84 45.94
Costs And Expenses
9.69%
54.94
50.09 53.95 50.04 45.95
Operating Income/Loss
1.19%
-49.26
-49.86 -46.63 -44.91 1.656
Income/Loss From Continuing Operations Before Tax
1.23%
-47.98
-48.57 -44.91 -20.71 1.661
Income Tax Expense/Benefit
180.18%
0.526
-0.656 0.687 0.68 0.625
Income/Loss From Continuing Operations After Tax
1.22%
-48.50
-47.92 -45.60 -21.39 1.036
Net Income/Loss
1.22%
-48.50
-47.92 -45.60 -21.39 1.036
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
2,656%
1,451.24
52.65 1,357.85 1,108.17 991.33
Diluted Average Shares
2,656%
1,451.24
52.65 1,357.85 1,108.17 1,000.28
Basic Earnings Per Share
0.00%
-0.03
-0.03 -0.03 -0.02 -
Diluted Earnings Per Share
0.00%
-0.03
-0.03 -0.03 -0.02 -
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$77.28
price up icon 2.02%
$20.39
price up icon 2.15%
$382.77
price up icon 1.58%
$53.29
price down icon 0.47%
$208.03
price up icon 0.38%
$110.97
price up icon 1.84%
Kapitalisierung:     |  Volumen (24h):